Full text is available at the source.
Abstract
Motor complications, particularly dyskinesia, affect many Parkinson's disease patients within years of levodopa therapy.
- Reliable biomarkers for motor complication subtypes in Parkinson's disease are currently lacking.
- Mitochondrial quality control pathways may play a significant role in the development of Parkinson's disease.
- The relationship between these mitochondrial pathways and motor complications is not yet fully understood.
Simplified